110 related articles for article (PubMed ID: 10360554)
1. A sorry affair.
Nature; 1999 May; 399(6734):285. PubMed ID: 10360554
[No Abstract] [Full Text] [Related]
2. Genentech stands by original data.
Henner DJ; Goeddel DV; Heyneker H; Itakura K; Yansura D; Ross M; Miozzari G
Nature; 1999 May; 399(6734):297-8. PubMed ID: 10360564
[No Abstract] [Full Text] [Related]
3. Statement from Peter Seeburg.
Seeburg PH
Nature; 1999 May; 399(6734):298. PubMed ID: 10360565
[No Abstract] [Full Text] [Related]
4. Charges fly in $1bn hormone patent battle.
Dalton R
Nature; 1999 May; 399(6734):289. PubMed ID: 10360558
[No Abstract] [Full Text] [Related]
5. Need for a court to rule on patents and misconduct.
Bihain BE
Nature; 2003 Aug; 424(6951):875. PubMed ID: 12931157
[No Abstract] [Full Text] [Related]
6. Genentech pays $200m over growth hormone 'theft'.
Dalton R; Schiermeier Q
Nature; 1999 Nov; 402(6760):335. PubMed ID: 10586857
[No Abstract] [Full Text] [Related]
7. UC-Genentech trial.
Henner D; Goeddel DV; Heyneker H; Itakura K; Tansura D
Science; 1999 May; 284(5419):1465. PubMed ID: 10383322
[No Abstract] [Full Text] [Related]
8. Scientific misconduct. Researcher rebuked for 20-year-old misdeed.
Hagmann M
Science; 1999 Dec; 286(5448):2249-50. PubMed ID: 10636777
[No Abstract] [Full Text] [Related]
9. Nontraditional publications and their effect on patentable inventions.
Garabedian TE
Nat Biotechnol; 2002 Apr; 20(4):401-2. PubMed ID: 11923849
[No Abstract] [Full Text] [Related]
10. UC-Genentech trial.
Seeburg PH
Science; 1999 May; 284(5419):1465-6. PubMed ID: 10383323
[No Abstract] [Full Text] [Related]
11. Quality patents.
Sinclair K
Australas Biotechnol; 1994; 4(5):284. PubMed ID: 7765675
[TBL] [Abstract][Full Text] [Related]
12. Patents stalemate on biotechnology.
Butler D
Nature; 1994 Dec; 372(6505):393. PubMed ID: 7984224
[No Abstract] [Full Text] [Related]
13. Inequitable Conduct and Invalidation of Patents Related to Food and Drug Administration-Regulated Products.
Tu SS; Leadmon C; Daval CJR; Kesselheim AS
JAMA; 2023 Dec; 330(21):2119-2121. PubMed ID: 37955942
[TBL] [Abstract][Full Text] [Related]
14. Equivalents in biotechnology patents.
Auer HE
Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574
[No Abstract] [Full Text] [Related]
15. When biotech goes bad.
Hodgson J
Nat Biotechnol; 2016 Mar; 34(3):284-91. PubMed ID: 26963551
[No Abstract] [Full Text] [Related]
16. "Ganske" threatens biotechnology patents worldwide.
Glaser V
Nat Biotechnol; 1997 Feb; 15(2):121. PubMed ID: 9035128
[No Abstract] [Full Text] [Related]
17. US acts to lengthen term of patents to help biotechnology.
Wadman M
Nature; 1999 Aug; 400(6745):604. PubMed ID: 10458149
[No Abstract] [Full Text] [Related]
18. Patents, biotechnology, and hematologic pathology.
Kettelberger DM; Gambrell P; McClung G
Hematol Pathol; 1992; 6(2):99-104. PubMed ID: 1607346
[No Abstract] [Full Text] [Related]
19. Patent prosecution of biotechnology and pharmaceutical patents in a changing legal landscape.
Lu DL; Kowalski TJ; Jarecki-Black J
Future Med Chem; 2010 Jan; 2(1):7-9. PubMed ID: 21426040
[No Abstract] [Full Text] [Related]
20. Biotechnology patents: strategies for meeting economic and ethical concerns.
Gold ER
Nat Genet; 2002 Apr; 30(4):359. PubMed ID: 11925560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
